Lutikizumab

Names

[ Name ]:
Lutikizumab

Biological Activity

[Description]:

Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis[1].

[Related Catalog]:

Signaling Pathways >> Immunology/Inflammation >> Interleukin Related

Research Areas >> Inflammation/Immunology

[In Vitro]

ABT-981 可同时结合人 IL-α 和 IL-1β 分子[1]。 ABT-981 对 IL-α 和 IL-1β 表现出高度特异性的结合作用相比于其他 IL-1 家族成员[1]。

[In Vivo]

Lutikizumab (0.0001-1 mg/kg，腹腔注射，1 次) 对 IL-1α 和 IL-1β 诱导的 IL-6 产生有效抑制作用[1]。 Animal Model: Female C57/BL6 mice with IL-1α and IL-1β injection[1] Dosage: 0.0001-1 mg/kg Administration: Intraperitoneal injection, 0.0001-1 mg/kg, once Result: Dose-dependently decreased the murine IL-6 generated by human and cynomolgus IL-1α and IL-1β.

[References]

[1]. Lacy SE, et al. Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β. MAbs. 2015;7(3):605-19.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.